We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer.
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that...
FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options to optimize shareholder value MALVERN, Pa., Nov...
Adriano Marchese Shares in Galera Therapeutics were halted from premarket trading on Tuesday after the Food and Drug Administration said the company needs an additional Phase 3 trial for its...
FDA confirms need for new trial for avasopasem for severe oral mucositis (SOM) GRECO-2 trial did not pass futility analysis; Company will discontinue both GRECO trials Company reviewing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0004 | 0.213333333333 | 0.1875 | 0.2165 | 0.162 | 664029 | 0.19091307 | CS |
4 | -0.00605 | -3.11936065996 | 0.19395 | 0.2385 | 0.1475 | 2967244 | 0.17843648 | CS |
12 | 0.0079 | 4.38888888889 | 0.18 | 0.29 | 0.1314 | 2071236 | 0.20142347 | CS |
26 | -0.0091 | -4.6192893401 | 0.197 | 0.29 | 0.0853 | 2551884 | 0.17466432 | CS |
52 | -2.5721 | -93.1920289855 | 2.76 | 3.59 | 0.0853 | 2655736 | 0.48404241 | CS |
156 | -6.3721 | -97.1356707317 | 6.56 | 10.79 | 0.0853 | 2110142 | 2.03151554 | CS |
260 | -12.3121 | -98.4968 | 12.5 | 19.5 | 0.0853 | 1431463 | 2.16371893 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions